메뉴 건너뛰기




Volumn 35, Issue 8, 2014, Pages 7407-7413

Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis

Author keywords

Hepatocellular carcinoma; Meta analysis; Radiofrequency ablation; Survival rate; Transarterial chemoembolization

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 84910652726     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1976-z     Document Type: Article
Times cited : (40)

References (31)
  • 2
    • 0141491273 scopus 로고    scopus 로고
    • Hepatocellular carcinoma
    • PID: 14667750
    • Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
    • (2003) Lancet , vol.362 , pp. 1907-1917
    • Llovet, J.M.1    Burroughs, A.2    Bruix, J.3
  • 3
    • 0036189111 scopus 로고    scopus 로고
    • Prognostic prediction and treatment strategy in hepatocellular carcinoma
    • PID: 11870363
    • Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–24.
    • (2002) Hepatology , vol.35 , pp. 519-524
    • Bruix, J.1    Llovet, J.M.2
  • 4
    • 0037308133 scopus 로고    scopus 로고
    • Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival
    • COI: 1:CAS:528:DC%2BD3sXhsFeltrg%3D, PID: 12540794
    • Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–42.
    • (2003) Hepatology , vol.37 , pp. 429-442
    • Llovet, J.M.1    Bruix, J.2
  • 5
    • 72949092477 scopus 로고    scopus 로고
    • Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 western patients with cirrhosis
    • PID: 19731239
    • N'Kontchou G, Mahamoudi A, Aout M, Ganne-Carrie N, Grando V, Coderc E, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 western patients with cirrhosis. Hepatology. 2009;50:1475–83.
    • (2009) Hepatology , vol.50 , pp. 1475-1483
    • N'Kontchou, G.1    Mahamoudi, A.2    Aout, M.3    Ganne-Carrie, N.4    Grando, V.5    Coderc, E.6
  • 6
    • 78751470154 scopus 로고    scopus 로고
    • Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study
    • PID: 20967759
    • Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F, et al. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 2011;53:136–47.
    • (2011) Hepatology , vol.53 , pp. 136-147
    • Rossi, S.1    Ravetta, V.2    Rosa, L.3    Ghittoni, G.4    Viera, F.T.5    Garbagnati, F.6
  • 7
    • 38649141497 scopus 로고    scopus 로고
    • Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?
    • PID: 18008357
    • Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 2008;47:82–9.
    • (2008) Hepatology , vol.47 , pp. 82-89
    • Livraghi, T.1    Meloni, F.2    Di Stasi, M.3    Rolle, E.4    Solbiati, L.5    Tinelli, C.6
  • 8
    • 33746528885 scopus 로고    scopus 로고
    • Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
    • COI: 1:CAS:528:DC%2BD28XpsFyks7Y%3D, PID: 16890600
    • Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461–9.
    • (2006) Gastroenterology , vol.131 , pp. 461-469
    • Takayasu, K.1    Arii, S.2    Ikai, I.3    Omata, M.4    Okita, K.5    Ichida, T.6
  • 9
    • 84856951551 scopus 로고    scopus 로고
    • Hepatocellular carcinomas 2–3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. Radiofrequency ablation alone
    • PID: 21353417
    • Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, et al. Hepatocellular carcinomas 2–3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. Radiofrequency ablation alone. Eur J Radiol. 2012;81:e189–93.
    • (2012) Eur J Radiol , vol.81 , pp. e189-e193
    • Kim, J.W.1    Kim, J.H.2    Won, H.J.3    Shin, Y.M.4    Yoon, H.K.5    Sung, K.B.6
  • 10
    • 79956199426 scopus 로고    scopus 로고
    • Medium-sized (3.1–5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone
    • PID: 21445671
    • Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, et al. Medium-sized (3.1–5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol. 2011;18:1624–9.
    • (2011) Ann Surg Oncol , vol.18 , pp. 1624-1629
    • Kim, J.H.1    Won, H.J.2    Shin, Y.M.3    Kim, S.H.4    Yoon, H.K.5    Sung, K.B.6
  • 11
    • 79960748644 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
    • COI: 1:STN:280:DC%2BC3MjhtlylsA%3D%3D, PID: 21766289
    • Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98:1210–24.
    • (2011) Br J Surg , vol.98 , pp. 1210-1224
    • Tiong, L.1    Maddern, G.J.2
  • 12
    • 84876411123 scopus 로고    scopus 로고
    • Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis
    • COI: 1:CAS:528:DC%2BC3sXltVCksLo%3D, PID: 23292073
    • Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2013;139:653–9.
    • (2013) J Cancer Res Clin Oncol , vol.139 , pp. 653-659
    • Ni, J.Y.1    Liu, S.S.2    Xu, L.F.3    Sun, H.L.4    Chen, Y.T.5
  • 13
    • 77954352223 scopus 로고    scopus 로고
    • Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis
    • PID: 20331507
    • Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int. 2010;30:741–9.
    • (2010) Liver Int , vol.30 , pp. 741-749
    • Wang, W.1    Shi, J.2    Xie, W.F.3
  • 14
    • 84879569695 scopus 로고    scopus 로고
    • Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma
    • PID: 23840128
    • Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2013;19:3872–82.
    • (2013) World J Gastroenterol , vol.19 , pp. 3872-3882
    • Ni, J.Y.1    Liu, S.S.2    Xu, L.F.3    Sun, H.L.4    Chen, Y.T.5
  • 15
    • 41949133133 scopus 로고    scopus 로고
    • Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial
    • COI: 1:CAS:528:DC%2BD1cXks1Wmtrw%3D, PID: 18398079
    • Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299:1669–77.
    • (2008) JAMA , vol.299 , pp. 1669-1677
    • Cheng, B.Q.1    Jia, C.Q.2    Liu, C.T.3    Fan, W.4    Wang, Q.L.5    Zhang, Z.L.6
  • 16
    • 84859001212 scopus 로고    scopus 로고
    • The Cochrane collaboration's tool for assessing risk of bias in randomised trials
    • PID: 22008217
    • Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
    • (2011) BMJ , vol.343 , pp. d5928
    • Higgins, J.P.1    Altman, D.G.2    Gotzsche, P.C.3    Juni, P.4    Moher, D.5    Oxman, A.D.6
  • 17
    • 0022992740 scopus 로고
    • Meta-analysis in clinical trials
    • COI: 1:STN:280:DyaL2s7gsVamtA%3D%3D, PID: 3802833
    • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
    • (1986) Control Clin Trials , vol.7 , pp. 177-188
    • DerSimonian, R.1    Laird, N.2
  • 18
    • 84959801619 scopus 로고
    • Statistical aspects of the analysis of data from retrospective studies of disease
    • COI: 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D, PID: 13655060
    • MANTEL N, HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
    • (1959) J Natl Cancer Inst , vol.22 , pp. 719-748
    • Mantel, N.1    Haenszel, W.2
  • 19
    • 84874771937 scopus 로고    scopus 로고
    • Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial
    • PID: 23269991
    • Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31:426–32.
    • (2013) J Clin Oncol , vol.31 , pp. 426-432
    • Peng, Z.W.1    Zhang, Y.J.2    Chen, M.S.3    Xu, L.4    Liang, H.H.5    Lin, X.J.6
  • 20
    • 84920941266 scopus 로고    scopus 로고
    • Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma
    • Aikata H, Shirakawa H, Takaki S. Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma. Hepatology 2006;44:A487nt 2013;33:375-383.
    • (2013) Hepatology 2006;44:A487nt , vol.33 , pp. 375-383
    • Aikata, H.1    Shirakawa, H.2    Takaki, S.3
  • 22
    • 84863143308 scopus 로고    scopus 로고
    • Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus rf ablation alone: a prospective randomized trial
    • PID: 22157201
    • Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus rf ablation alone: a prospective randomized trial. Radiology. 2012;262:689–700.
    • (2012) Radiology , vol.262 , pp. 689-700
    • Peng, Z.W.1    Zhang, Y.J.2    Liang, H.H.3    Lin, X.J.4    Guo, R.P.5    Chen, M.S.6
  • 23
    • 78649570066 scopus 로고    scopus 로고
    • Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization
    • PID: 20672352
    • Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer. 2010;116:5452–60.
    • (2010) Cancer , vol.116 , pp. 5452-5460
    • Morimoto, M.1    Numata, K.2    Kondou, M.3    Nozaki, A.4    Morita, S.5    Tanaka, K.6
  • 24
    • 70349283138 scopus 로고    scopus 로고
    • Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    • PID: 19567647
    • Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology. 2009;252:905–13.
    • (2009) Radiology , vol.252 , pp. 905-913
    • Shibata, T.1    Isoda, H.2    Hirokawa, Y.3    Arizono, S.4    Shimada, K.5    Togashi, K.6
  • 25
    • 58749105130 scopus 로고    scopus 로고
    • Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC
    • COI: 1:CAS:528:DC%2BD1cXhsV2ksbjO, PID: 18670743
    • Yang P, Liang M, Zhang Y, Shen B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv Ther. 2008;25:787–94.
    • (2008) Adv Ther , vol.25 , pp. 787-794
    • Yang, P.1    Liang, M.2    Zhang, Y.3    Shen, B.4
  • 26
    • 77249142235 scopus 로고    scopus 로고
    • Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis
    • COI: 1:CAS:528:DC%2BC3cXisFejtro%3D, PID: 20149473
    • Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgro G, Burroughs AK. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J Hepatol. 2010;52:380–8.
    • (2010) J Hepatol , vol.52 , pp. 380-388
    • Germani, G.1    Pleguezuelo, M.2    Gurusamy, K.3    Meyer, T.4    Isgro, G.5    Burroughs, A.K.6
  • 28
    • 61949290827 scopus 로고    scopus 로고
    • Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies
    • PID: 19065676
    • Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009;49:453–9.
    • (2009) Hepatology , vol.49 , pp. 453-459
    • Cho, Y.K.1    Kim, J.K.2    Kim, M.Y.3    Rhim, H.4    Han, J.K.5
  • 29
    • 84899094797 scopus 로고    scopus 로고
    • Comparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma
    • COI: 1:CAS:528:DC%2BC2cXltlyqt7Y%3D, PID: 24197985
    • Kong QF, Jiao JB, Chen QQ, Li L, Wang DG, Lv B. Comparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma. Tumour Biol. 2014;35:2655–9.
    • (2014) Tumour Biol , vol.35 , pp. 2655-2659
    • Kong, Q.F.1    Jiao, J.B.2    Chen, Q.Q.3    Li, L.4    Wang, D.G.5    Lv, B.6
  • 30
    • 84898818648 scopus 로고    scopus 로고
    • Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma
    • COI: 1:CAS:528:DC%2BC2cXmtlWltrY%3D, PID: 24277379
    • Jiang G, Xu X, Ren S, Wang L. Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma. Tumour Biol. 2014;35:3405–8.
    • (2014) Tumour Biol , vol.35 , pp. 3405-3408
    • Jiang, G.1    Xu, X.2    Ren, S.3    Wang, L.4
  • 31
    • 1942444404 scopus 로고    scopus 로고
    • Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin
    • PID: 15022021
    • Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg. 2004;28:376–81.
    • (2004) World J Surg , vol.28 , pp. 376-381
    • Shi, M.1    Zhang, C.Q.2    Zhang, Y.Q.3    Liang, X.M.4    Li, J.Q.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.